For coal workers' pneumoconiosis, deaths have decreased in the US since the early 2000s.[1]Bell JL, Mazurek JM. Trends in pneumoconiosis deaths - United States, 1999-2018. MMWR Morb Mortal Wkly Rep. 2020 Jun 12;69(23):693-8.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7315788
http://www.ncbi.nlm.nih.gov/pubmed/32525855?tool=bestpractice.com
The number of deaths recorded in 1999 was 1002, compared to 305 in 2018.[1]Bell JL, Mazurek JM. Trends in pneumoconiosis deaths - United States, 1999-2018. MMWR Morb Mortal Wkly Rep. 2020 Jun 12;69(23):693-8.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7315788
http://www.ncbi.nlm.nih.gov/pubmed/32525855?tool=bestpractice.com
In the UK, data published by the Health and Safety Executive (HSE) indicate that there are an average of 130 deaths per year from coal workers' pneumoconiosis.[2]Health and Safety Executive. Silicosis and coal workers' pneumoconiosis statistics in Great Britain, 2022. Nov 2022 [internet publication].
https://www.hse.gov.uk/statistics/causdis/pneumoconiosis-and-silicosis.pdf
In terms of prevalence, a general downward trend has been observed, with the pooled prevalence in China, Europe and the US declining from 6.0% to 2.3% between the 1980s and 2010s.[3]Liu W, Liang R, Zhang R, et al. Prevalence of coal worker's pneumoconiosis: a systematic review and meta-analysis. Environ Sci Pollut Res Int. 2022 Dec;29(59):88690-8.
http://www.ncbi.nlm.nih.gov/pubmed/35836046?tool=bestpractice.com
However, a small resurgence in prevalence has been observed since the late 2010s in major coal-producing countries such as the US and Australia.[4]Blackley DJ, Halldin CN, Laney AS. Continued increase in prevalence of coal workers' pneumoconiosis in the United States, 1970-2017. Am J Public Health. 2018 Sep;108(9):1220-2.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6085042
http://www.ncbi.nlm.nih.gov/pubmed/30024799?tool=bestpractice.com
[5]Zosky GR, Hoy RF, Silverstone EJ, et al. Coal workers' pneumoconiosis: an Australian perspective. Med J Aust. 2016 Jun 20;204(11):414-8.
http://www.ncbi.nlm.nih.gov/pubmed/27318401?tool=bestpractice.com
[6]De Matteis S, Heederik D, Burdorf A, et al. Current and new challenges in occupational lung diseases. Eur Respir Rev. 2017 Dec 31;26(146):170080.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6033059
http://www.ncbi.nlm.nih.gov/pubmed/29141963?tool=bestpractice.com
Silicosis mortality has also continued to decrease in the US, with 185 deaths recorded in 1999 compared to 87 in 2018.[1]Bell JL, Mazurek JM. Trends in pneumoconiosis deaths - United States, 1999-2018. MMWR Morb Mortal Wkly Rep. 2020 Jun 12;69(23):693-8.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7315788
http://www.ncbi.nlm.nih.gov/pubmed/32525855?tool=bestpractice.com
In the UK, HSE data show that there are an average of 12 deaths per year from silicosis.[2]Health and Safety Executive. Silicosis and coal workers' pneumoconiosis statistics in Great Britain, 2022. Nov 2022 [internet publication].
https://www.hse.gov.uk/statistics/causdis/pneumoconiosis-and-silicosis.pdf
Globally, mortality from silicosis is decreasing, although a rise in prevalence has been observed in countries such as China and India.[7]Chen S, Liu M, Xie F. Global and national burden and trends of mortality and disability-adjusted life years for silicosis, from 1990 to 2019: results from the Global Burden of Disease study 2019. BMC Pulm Med. 2022 Jun 21;22(1):240.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9210623
http://www.ncbi.nlm.nih.gov/pubmed/35729551?tool=bestpractice.com
[8]Cullinan P, Muñoz X, Suojalehto H, et al. Occupational lung diseases: from old and novel exposures to effective preventive strategies. Lancet Respir Med. 2017 May;5(5):445-55.
https://spiral.imperial.ac.uk/handle/10044/1/65052
http://www.ncbi.nlm.nih.gov/pubmed/28089118?tool=bestpractice.com
[9]Li J, Yin P, Wang H, et al. The burden of pneumoconiosis in China: an analysis from the Global Burden of Disease Study 2019. BMC Public Health. 2022 Jun 3;22(1):1114.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9166455
http://www.ncbi.nlm.nih.gov/pubmed/35659279?tool=bestpractice.com
Mortality is not a good measure of the burden of silicosis, as the occurrence of the disease is much more common than its recording on a death certificate. In the US, an estimated 3260 to 7105 individuals are hospitalised with silicosis annually.[10]Casey ML, Mazurek JM. Silicosis prevalence and incidence among Medicare beneficiaries. Am J Ind Med. 2019 Mar;62(3):183-91.
http://www.ncbi.nlm.nih.gov/pubmed/30658007?tool=bestpractice.com
New cases of silicosis continue to emerge as the result of the growth of new industries, for example engineered countertops.[11]Hoy RF. Artificial stone silicosis. Curr Opin Allergy Clin Immunol. 2021 Apr 1;21(2):114-20.
http://www.ncbi.nlm.nih.gov/pubmed/33332924?tool=bestpractice.com
Beryllium sensitisation precedes chronic beryllium disease, although only around one third of cases of confirmed sensitisation will progress to disease.[12]Newman LS, Mroz MM, Balkissoon R, et al. Beryllium sensitization progresses to chronic beryllium disease: a longitudinal study of disease risk. Am J Respir Crit Care Med. 2005 Jan 1;171(1):54-60.
https://www.atsjournals.org/doi/full/10.1164/rccm.200402-190OC
http://www.ncbi.nlm.nih.gov/pubmed/15374840?tool=bestpractice.com
Studies investigating the prevalence and mortality associated with chronic beryllium disease are limited. In the US, prevalence appears highest amongst those working at beryllium processing facilities and historically nuclear weapons production facilities, with an estimated mortality rate of 7.8%.[13]Balmes JR, Abraham JL, Dweik RA, et al. An official American Thoracic Society statement: diagnosis and management of beryllium sensitivity and chronic beryllium disease. Am J Respir Crit Care Med. 2014 Nov 15;190(10):e34-59.
https://www.atsjournals.org/doi/full/10.1164/rccm.201409-1722ST?url_ver=Z39.88-2003&rfr_id=ori%3Arid%3Acrossref.org&rfr_dat=cr_pub%3Dpubmed
http://www.ncbi.nlm.nih.gov/pubmed/25398119?tool=bestpractice.com
[14]Cloeren M, Dement J, Gaitens J, et al. Beryllium disease among construction trade workers at Department of Energy nuclear sites: A follow-up. Am J Ind Med. 2022 Sep;65(9):708-20.
http://www.ncbi.nlm.nih.gov/pubmed/35833586?tool=bestpractice.com
[15]Schubauer-Berigan MK, Couch JR, Petersen MR, et al. Cohort mortality study of workers at seven beryllium processing plants: update and associations with cumulative and maximum exposure. Occup Environ Med. 2011 May;68(5):345-53.
http://www.ncbi.nlm.nih.gov/pubmed/20952555?tool=bestpractice.com
The general downward trend for pneumoconioses mortality is likely attributable to fewer people working in high-risk industries, as well as significant improvements in health and safety measures. Controls in the US to reduce workers' exposures were first promulgated in the early 1970s. There is a latency period of around 20 years from time of first exposure to silica or coal and the development of radiographic changes, so the diagnosis is typically seen in people who began working with silica or coal prior to the 1980s. These people are now usually >50 years old. However, a more aggressive form of silicosis (accelerated silicosis), with short duration but heavier exposure, can occur. This is also true for coal workers, where miners exposed since 1980 with only 15 to 20 years of exposure have developed pneumoconiosis. Some of these people have disease that has developed into progressive massive fibrosis.[16]Antao VC, Petsonk EL, Sokolow LZ, et al. Rapidly progressive coal workers' pneumoconiosis in the United States: geographic clustering and other factors. Occup Environ Med. 2005 Oct;62(10):670-4.
http://oem.bmj.com/content/62/10/670.long
http://www.ncbi.nlm.nih.gov/pubmed/16169911?tool=bestpractice.com
[17]Blackley DJ, Reynolds LE, Short C, et al. Progressive massive fibrosis in coal miners from 3 clinics in Virginia. JAMA. 2018 Feb 6;319(5):500-1.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5839295
http://www.ncbi.nlm.nih.gov/pubmed/29411024?tool=bestpractice.com
There is no evidence of such a latency for chronic beryllium disease. The risk of its development is highly dependent on the presence of certain genetic polymorphisms of the human leukocyte antigen (HLA) genes, and it has occurred after low reported exposure.[18]McCanlies EC, Kreiss K, Andrew M, et al. HLA-DPB1 and chronic beryllium disease: a HuGE review. Am J Epidemiol. 2003 Mar 1;157(5):388-98.
https://academic.oup.com/aje/article/157/5/388/76647/HLA-DPB1-and-Chronic-Beryllium-Disease-A-HuGE
http://www.ncbi.nlm.nih.gov/pubmed/12615603?tool=bestpractice.com